Skip to main content
. 2021 Dec 3;13(12):2075. doi: 10.3390/pharmaceutics13122075

Figure 3.

Figure 3

Cytotoxicity and cellular uptake into HeLa cells. (A) Cytotoxicity profile of CB-peptide conjugates towards HeLa cells. (B) CLSM analysis of 1 µM CF-labeled peptide conjugates after 2 h of incubation in HeLa cells; scale bar: 10 µm. (C) Flow cytometry analysis of 1 µM CF-labeled peptide conjugates after 2 h of incubation in HeLa cells. Significances were determined by Student’s t-test (** p < 0.005; *** p < 0.0005). CB4-sC18 is significant (*** p < 0.0005) to all conjugates.